TI
GMAB icon

Tidal Investments’s Genmab GMAB Stock Holding History

Tidal Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Sell
162,384
-21,740
-12% -$578K 0.01% 981
2026
Q1 		$4.94M Buy
+184,124
New +$5.52M 0.01% 812

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tidal Investments's GMAB Position: Q2 2026 in Review

Tidal Investments reduced its Genmab (GMAB) stake by 12% in Q2 2026, selling an estimated $578K and leaving 162,384 shares worth $4.46M. The position accounts for 0.01% of the portfolio, ranked #981.

Tidal Investments first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.94M in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Tidal Investments held 162,384 shares of Genmab worth $4.46M as of Q2 2026.
  • Tidal Investments sold 21,740 Genmab shares in Q2 2026, an estimated $578K.
  • Genmab made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #981 holding.
  • Tidal Investments first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • Tidal Investments's Genmab position peaked at $4.94M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.